OmniAb Future Growth
Future criteria checks 2/6
OmniAb is forecast to grow earnings and revenue by 29.3% and 28.3% per annum respectively while EPS is expected to grow by 34.5% per annum.
Key information
29.3%
Earnings growth rate
34.5%
EPS growth rate
Life Sciences earnings growth | 17.8% |
Revenue growth rate | 28.3% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 16 Aug 2024 |
Recent future growth updates
Recent updates
Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 43%?
Jul 15The OmniAb, Inc. (NASDAQ:OABI) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 12Things Look Grim For OmniAb, Inc. (NASDAQ:OABI) After Today's Downgrade
Mar 26Revenues Not Telling The Story For OmniAb, Inc. (NASDAQ:OABI)
Feb 28OmniAb, Inc.'s (NASDAQ:OABI) Intrinsic Value Is Potentially 37% Above Its Share Price
Jan 15Unpleasant Surprises Could Be In Store For OmniAb, Inc.'s (NASDAQ:OABI) Shares
Nov 11Earnings Update: OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Are Trimming Their Forecasts
Aug 13OmniAb, Inc. (NASDAQ:OABI) Analysts Just Cut Their EPS Forecasts Substantially
May 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 71 | -29 | 9 | N/A | 6 |
12/31/2025 | 54 | -43 | -44 | N/A | 7 |
12/31/2024 | 31 | -60 | -47 | N/A | 8 |
6/30/2024 | 22 | -62 | -47 | -45 | N/A |
3/31/2024 | 21 | -63 | -45 | -42 | N/A |
12/31/2023 | 34 | -51 | 1 | 2 | N/A |
9/30/2023 | 65 | -30 | -2 | 4 | N/A |
6/30/2023 | 66 | -27 | -4 | 6 | N/A |
3/31/2023 | 66 | -22 | -1 | 12 | N/A |
12/31/2022 | 59 | -22 | -21 | -4 | N/A |
9/30/2022 | 39 | -32 | -15 | -1 | N/A |
6/30/2022 | 38 | -28 | -12 | -1 | N/A |
3/31/2022 | 38 | -25 | -3 | 4 | N/A |
12/31/2021 | 35 | -27 | -10 | -6 | N/A |
9/30/2021 | 33 | -24 | -2 | 0 | N/A |
12/31/2020 | 23 | -18 | 4 | 4 | N/A |
12/31/2019 | 18 | -14 | -5 | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OABI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OABI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OABI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OABI's revenue (28.3% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: OABI's revenue (28.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OABI's Return on Equity is forecast to be high in 3 years time